How much does it cost to take bedaquiline for 6 months?

Bedaquiline (Bedaquiline) is a new anti-tuberculosis drug specifically used to treat multidrug-resistant tuberculosis (MDR-TB), developed by Janssen Pharmaceuticals. It was approved by the US FDA in 2012, becoming the first new anti-tuberculosis drug to be released in 40 years. Its main mechanism of action is to inhibit the activity of Mycobacterium tuberculosis ATP synthase and block the energy production of bacteria, thus leading to bacterial death. ATPSynthase is an important enzyme for energy metabolism in bacterial cells, so bedaquiline has shown high efficacy in the treatment of drug-resistant tuberculosis, especially when used in combination with other anti-tuberculosis drugs.

Bedaquiline is already on the market in China and has been included in medical insurance to reduce the financial burden on patients. When purchased domestically, the common specification is 100mg*24 tablets, and the price per box is about six to seven thousand yuan. However, the specific costs and medical insurance reimbursement ratios vary in different regions, and patients should confirm according to the policies of local hospitals or pharmacies. In addition, the treatment cycle of bedaquiline is usually 24 weeks (6 months), and the cost may be adjusted based on the dosage and total number of treatment courses. The final cost will drop significantly after medical insurance reimbursement.

In the international market, the price of bedaquiline varies significantly. Among foreign original drugs, the Russian version is relatively cheap. The price of 100mg188 tablets is more than 10,000 yuan, which is more cost-effective than the domestic version. In terms of generic drugs, the price of Indian generic drugs 100mg188 tablets is only more than 2,000 yuan, and the ingredients are basically the same as the original drugs. This provides a more economical option for patients who have the conditions to purchase drugs through overseas channels, but they must pay attention to the source reliability and safety of use of imported drugs.

In short, bedaquiline, as a key drug in the treatment of multidrug-resistant tuberculosis, has greatly improved the prognosis of patients, especially after being included in medical insurance, reducing the cost of treatment. However, it must be used under the guidance of a doctor, and potential side effects such as heart and liver function must be strictly monitored.